首页 > 最新文献

Healthcare Administration Leadership & Management Journal最新文献

英文 中文
Congestive Heart Failure Readmission Rates Decline After Patient Navigator Implementation in COVID-19 Era COVID-19时代实施患者导航后充血性心力衰竭再入院率下降
Pub Date : 2023-10-01 DOI: 10.55834/halmj.3128955612
Jason Lauf, Elizabeth Keller, Anthony Miniaci, Meghan Ramic, Farshad Forouzandeh, James Hill
Heart failure is a leading cause of hospitalizations, with a growing prevalence and a high readmission rate. Hospitalization and readmission affect both patient stress and hospital finances. The COVID-19 pandemic and broader economic conditions placed additional stress on hospitals in recent years. In response, our hospital implemented a heart failure navigator program during the COVID-19 pandemic to prevent readmissions. We monitored the readmission and mortality rates of patients hospitalized for heart failure in 2018 and 2019 (before implementation) against 2020 and 2021 (after implementation). There were 235 readmissions with 28 deaths before implementation and 156 readmissions with 17 deaths after implementation. The reduction in readmission was significant (p = .0185), with an insignificant reduction in mortality (p = .2674). This indicates that the reduction in readmission rate was secondary to navigator implementation, not patient mortality. In conclusion, a multifactorial HF navigator can reduce HF readmission, even when implemented during a pandemic that causes increased patient morbidity.
心力衰竭是住院治疗的主要原因,发病率不断上升,再入院率也很高。住院和再入院会影响病人的压力和医院的财务状况。近年来,COVID-19大流行和更广泛的经济状况给医院带来了额外的压力。为此,我们医院在COVID-19大流行期间实施了心力衰竭导航计划,以防止再入院。我们监测了2018年和2019年(实施前)与2020年和2021年(实施后)因心力衰竭住院患者的再入院率和死亡率。实施前有235人再入院,28人死亡,实施后有156人再入院,17人死亡。再入院率显著降低(p = 0.0185),死亡率不显著降低(p = 0.2674)。这表明再入院率的降低是继发于导航器的实施,而不是患者死亡率。总之,多因素心衰导航可以减少心衰再入院,即使在导致患者发病率增加的大流行期间实施也是如此。
{"title":"Congestive Heart Failure Readmission Rates Decline After Patient Navigator Implementation in COVID-19 Era","authors":"Jason Lauf, Elizabeth Keller, Anthony Miniaci, Meghan Ramic, Farshad Forouzandeh, James Hill","doi":"10.55834/halmj.3128955612","DOIUrl":"https://doi.org/10.55834/halmj.3128955612","url":null,"abstract":"Heart failure is a leading cause of hospitalizations, with a growing prevalence and a high readmission rate. Hospitalization and readmission affect both patient stress and hospital finances. The COVID-19 pandemic and broader economic conditions placed additional stress on hospitals in recent years. In response, our hospital implemented a heart failure navigator program during the COVID-19 pandemic to prevent readmissions. We monitored the readmission and mortality rates of patients hospitalized for heart failure in 2018 and 2019 (before implementation) against 2020 and 2021 (after implementation). There were 235 readmissions with 28 deaths before implementation and 156 readmissions with 17 deaths after implementation. The reduction in readmission was significant (p = .0185), with an insignificant reduction in mortality (p = .2674). This indicates that the reduction in readmission rate was secondary to navigator implementation, not patient mortality. In conclusion, a multifactorial HF navigator can reduce HF readmission, even when implemented during a pandemic that causes increased patient morbidity.","PeriodicalId":500441,"journal":{"name":"Healthcare Administration Leadership & Management Journal","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135323151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Hospital Consolidation Leading to Higher Value? 医院整合会带来更高的价值吗?
Pub Date : 2023-10-01 DOI: 10.55834/halmj.9462789854
Robert Smoldt, Natalie Landman, Benjamin Weinstock, Denis Cortese
Hospital consolidation is on the rise, driven by the combination of government provisions that aim to move the system from volume to value and the financial impacts of the pandemic. The key argument in favor of consolidation is that larger systems are better positioned to achieve higher value through dissemination of best practices and economies of scale. So, are these systems delivering consistently high value? Our analysis of the CMS Hospital Value-Based Purchasing Total Performance Score (TPS) for two cohorts of health systems — those in the state of California and those top ranked by U.S. News & World Report— suggests that the answer is: it depends. Although in some systems, most hospitals have higher-than-average TPS, all systems show opportunities for improvement. Given that patients often assume within-brand equivalence in healthcare value judgements, hospital systems must assume responsibility for delivering truly consistent and high value healthcare across their entire network.
医院整合正在增加,这是由旨在将系统从数量转向价值的政府规定和大流行的财务影响共同推动的。支持合并的关键论点是,通过传播最佳实践和规模经济,更大的系统能够更好地实现更高的价值。那么,这些系统是否始终提供高价值?我们对CMS医院基于价值的采购总绩效评分(TPS)的两组医疗系统进行了分析——加利福尼亚州的医疗系统和美国新闻与世界报道排名靠前的医疗系统。《世界报告》表明,答案是:视情况而定。虽然在某些系统中,大多数医院的TPS高于平均水平,但所有系统都显示出改进的机会。考虑到患者在医疗保健价值判断中经常假设品牌内等同,医院系统必须承担起在整个网络中提供真正一致和高价值医疗保健的责任。
{"title":"Is Hospital Consolidation Leading to Higher Value?","authors":"Robert Smoldt, Natalie Landman, Benjamin Weinstock, Denis Cortese","doi":"10.55834/halmj.9462789854","DOIUrl":"https://doi.org/10.55834/halmj.9462789854","url":null,"abstract":"Hospital consolidation is on the rise, driven by the combination of government provisions that aim to move the system from volume to value and the financial impacts of the pandemic. The key argument in favor of consolidation is that larger systems are better positioned to achieve higher value through dissemination of best practices and economies of scale. So, are these systems delivering consistently high value? Our analysis of the CMS Hospital Value-Based Purchasing Total Performance Score (TPS) for two cohorts of health systems — those in the state of California and those top ranked by U.S. News & World Report— suggests that the answer is: it depends. Although in some systems, most hospitals have higher-than-average TPS, all systems show opportunities for improvement. Given that patients often assume within-brand equivalence in healthcare value judgements, hospital systems must assume responsibility for delivering truly consistent and high value healthcare across their entire network.","PeriodicalId":500441,"journal":{"name":"Healthcare Administration Leadership & Management Journal","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135323160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Healthcare Administration Leadership & Management Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1